WallStreetZenWallStreetZen

NASDAQ: NEO
Neogenomics Inc Earnings & Revenue

NEO past revenue growth

How has NEO's revenue growth performed historically?
Company
15.27%
Industry
1.5%
Market
20.14%
NEO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NEO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NEO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NEO earnings and revenue history

Current Revenue
$610.7M
Current Earnings
-$84.2M
Current Profit Margin
-13.8%

NEO Return on Equity

Current Company
-8.9%
Current Industry
-10.3%
Current Market
28.2%
NEO's Return on Equity (-8.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NEO announces earnings.

NEO Return on Assets

Current Company
-5%
Current Industry
6.4%
NEO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NEO Return on Capital Employed

Current Company
-5.18%
Current Industry
11.4%
NEO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NEO vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NEO$610.66M$1.33M-$84.23M+14.60%N/A
MYGN$774.20M-$163.70M-$234.60M-1.37%N/A
OPK$799.60M-$128.11M-$252.43M-3.55%N/A
LAB$126.76M-$76.45M-$135.98M+1.47%N/A
CDNA$275.11M-$175.06M-$183.19M+25.46%N/A

NEO earnings dates

Next earnings date
Aug 6, 2024

Neogenomics Earnings & Revenue FAQ

What were NEO's earnings last quarter?

On Invalid Date, Neogenomics (NASDAQ: NEO) reported Q1 2024 earnings per share (EPS) of -$0.21, up 16% year over year. Total Neogenomics earnings for the quarter were -$27.06 million. In the same quarter last year, Neogenomics's earnings per share (EPS) was -$0.25.

If you're new to stock investing, here's how to buy Neogenomics stock.

What was NEO's earnings growth in the past year?

As of Q2 2024, Neogenomics's earnings has grown year over year. Neogenomics's earnings in the past year totalled -$84.23 million.

What is NEO's earnings date?

Neogenomics's earnings date is Invalid Date. Add NEO to your watchlist to be reminded of NEO's next earnings announcement.

What was NEO's revenue last quarter?

On Invalid Date, Neogenomics (NASDAQ: NEO) reported Q1 2024 revenue of $156.24 million up 13.86% year over year. In the same quarter last year, Neogenomics's revenue was $137.22 million.

What was NEO's revenue growth in the past year?

As of Q2 2024, Neogenomics's revenue has grown 15.27% year over year. This is 13.77 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.5%. Neogenomics's revenue in the past year totalled $610.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.